688621.SS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 22:51):

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China...

Stats
Today's Volume	257 326
Average Volume	1.00M
Market Cap	6.39B
EPS	CNY0 ( 2023-10-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	32.21
ATR14	CNY0.115 (0.20%)

Volume Correlation

Long: 0.05 (neutral)

Short: 0.49 (neutral)

Signal:(47.411) Neutral

Beijing Sun-Novo Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Beijing Sun-Novo Correlation - Currency/Commodity

-0.32
( neutral )

0.14
( neutral )

0.00
( neutral )

-0.25
( neutral )

-0.27
( neutral )

0.24
( neutral )

Beijing Sun-Novo Financials

Annual	2022
Revenue:	CNY676.61M
Gross Profit:	CNY375.46M (55.49 %)
EPS:	CNY1.390

Q3	2023
Revenue:	CNY230.96M
Gross Profit:	CNY125.71M (54.43 %)
EPS:	CNY0.470

Q2	2023
Revenue:	CNY228.61M
Gross Profit:	CNY147.90M (64.69 %)
EPS:	CNY0.630

Q1	2023
Revenue:	CNY232.43M
Gross Profit:	CNY114.56M (49.29 %)
EPS:	CNY0.430

Financial Reports:

No articles found.

Beijing Sun-Novo

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China. The company offers small molecule chemical generic drugs; peptide products; and drugs for indications, such as impetigo, acne, renal anemia, chronic kidney disease dialysis patient hyper parathyroid hormone, analgesia, and other symptoms. It also provides packaging material compatibility test, impurity research, extract research, migration research, safety evaluation, and other research services; consistency evaluation services; clinical research services; registration consulting and agency services; and range of pharmacokinetics-pharmacodynamics and GLP bioanalysis services, including pharmacokinetic bioanalysis, immunogenic biology analysis, pharmacodynamics, and biomarker bioanalysis services. The company was founded in 2009 and is based in Beijing, China.